Does BICALUTAMIDE Cause Therapy cessation? 14 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 14 reports of Therapy cessation have been filed in association with BICALUTAMIDE (Bicalutamide). This represents 0.3% of all adverse event reports for BICALUTAMIDE.
14
Reports of Therapy cessation with BICALUTAMIDE
0.3%
of all BICALUTAMIDE reports
3
Deaths
5
Hospitalizations
How Dangerous Is Therapy cessation From BICALUTAMIDE?
Of the 14 reports, 3 (21.4%) resulted in death, 5 (35.7%) required hospitalization, and 2 (14.3%) were considered life-threatening.
Is Therapy cessation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BICALUTAMIDE. However, 14 reports have been filed with the FAERS database.
What Other Side Effects Does BICALUTAMIDE Cause?
Malignant neoplasm progression (352)
Prostatic specific antigen increased (322)
Drug ineffective (268)
Fatigue (258)
Prostate cancer (258)
Asthenia (223)
Hot flush (219)
Off label use (171)
Disease progression (169)
Anaemia (164)
What Other Drugs Cause Therapy cessation?
DALFAMPRIDINE (4,580)
ETANERCEPT (2,031)
ADALIMUMAB (1,712)
ABIRATERONE (1,602)
VOXELOTOR (1,038)
CLOZAPINE (885)
LOMITAPIDE (828)
CAPECITABINE (746)
TREPROSTINIL (743)
ISOTRETINOIN (633)
Which BICALUTAMIDE Alternatives Have Lower Therapy cessation Risk?
BICALUTAMIDE vs BICTEGRAVIR
BICALUTAMIDE vs BICTEGRAVIR\EMTRICITABINE\TENOFOVIR ALAFENAMIDE
BICALUTAMIDE vs BIFIDOBACTERIUM LONGUM
BICALUTAMIDE vs BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS
BICALUTAMIDE vs BILASTINE